| Company name | TOKIWA Pharmaceutical Co., Ltd. |
|---|---|
| Address | Sumitomo Seimei Honmachi Bldg.9F, 3-5-12 Azuchi-machi, Chuo-ku, Osaka, Japan |
| Date of Establishment | October, 1946 |
| Date of Incorporation | March, 1949 |
| Capital | 4,301,265 thousand Japanese Yen [Shareholders] Noevir Co., Ltd. 100% |
| Director | President and Representative Director
Masataka Nakano |
| No.Of Employees | As of January 1, 2009 Non-consolidated : 747(male:505, female:242) Consolidated : 1,117(male:819, female:298) * Directors/corporate officers, advisors, and part-time/temporary staff are excluded |
| Lines of Business | Tokiwa develops, manufactures and markets pharmaceuticals, quasi-drugs, cosmetics and health food products. |
| Offices | [Headquarters] Tokyo, Osaka and Kobe [Location of Offices] Sapporo, Sendai, Saitama, Tokyo, Nagoya, Osaka, Hiroshima, Takamatsu and Fukuoka. [Location of R&D/Factory] Mie |
| Affiliated company | Tokiwa Medical Service Co., Ltd. |
| March, 1949 | Incorporated TOKIWA Pharmaceutical Co.,Ltd. |
|---|---|
| November, 1985 | NOV Co., Ltd. business initiated |
| June, 1986 | Incorporated SANA Co., Ltd. |
| September, 2004 | Three subsidiary companies, Tokiwa Pharmaceutical, NOV and SANA, under Noevir Co., Ltd. merged as part of its subsidiary reorganization |